Art. 4 Directive (EU) 1996/22

In forcesince 18 Dec 2008cited 10×

Notwithstanding Articles 2 and 3, Member States may authorize:

1.

the administering to farm animals, for therapeutic purposes, of oestradiol 17 β, testosterone and progesterone and derivatives which readily yield the parent compound on hydrolysis after absorption at the site of application. Veterinary medicinal products used for therapeutic treatment must comply with the requirements for placing on the market laid down in Directive 81/851/EEC and be administered only by a veterinarian, by injection or for the treatment of ovarian dysfunction in the form of vaginal spirals, but not by implant, to farm animals which have been clearly identified. Treatment of identified animals must be registered by the veterinarian responsible. The latter must record at least the following details in a register, which may be the one provided for in Directive 81/851/EEC:

type of treatment,

the type of products authorized,

the date of treatment,

the identity of the animals treated.

The register must be made available to the competent authority at its request;

2.

the administering for therapeutic purposes of authorized veterinary medicinal products containing:

(i)

allyl trenbolone, administered orally, or beta-agonists to equidae, provided they are used in accordance with the manufacturer’s instructions;

(ii)

beta-agonists, in the form of an injection to induce tocolysis in cows when calving.

Such substances must be administered by a veterinarian or, in the case of the veterinary medicinal products referred to in (i), under his direct responsibility; treatment must be registered by the veterinarian responsible, who shall record at least the details referred to in point 1.

Farmers shall be prohibited from holding veterinary medicinal products containing beta-agonists which may be used for induction purposes in the treatment of tocolysis.

However, without prejudice to the first subparagraph of point 2 (ii), therapeutic treatment of production animals, including breeding animals at the end of their reproductive life, shall be prohibited.

  • Judgment of the Court of First Instance (Second Chamber) of 1 December 1999. Boehringer Ingelheim Vetmedica GmbH and C.H. Boehringer Sohn v Decision

    It should be noted in that respect that the applicants misinterpret Directive 96/22 where they maintain that it entails, de facto, a prohibition on the administration of any beta-agonists for the treatment of respiratory problems in …

    1 Dec 1999 · 61996TJ0125

  • Judgment of the Court (Grand Chamber) of 12 July 2005. Commission of the European Communities v CEVA Santé Animale SA and Pfizer EnterprisesDecision

    Article 4 of that directive provides that Member States may, by way of derogation and subject to certain conditions, authorise the administration of progesterone to farm animals for therapeutic purposes.

    12 Jul 2005 · 62003CJ0198

  • Judgment of the Court of 26 February 2002. Commission of the European Communities v Boehringer Ingelheim Vetmedica GmbH and C. H. BoehringerDecision

    In accordance with point 2 of the first paragraph of Article 4 of Directive 96/22, the Member States may, by way of derogation from Articles 2 and 3, authorise the administering for therapeutic purposes of authorised veterinary medicinal …

    26 Feb 2002 · 62000CJ0032

  • Judgment of the Court of 26 February 2002. Council of the European Union v Boehringer Ingelheim Vetmedica GmbH and C. H. Boehringer Sohn.Decision

    In accordance with point 2 of the first paragraph of Article 4 of Directive 96/22, the Member States may, by way of derogation from Articles 2 and 3, authorise the administering for therapeutic purposes of authorised veterinary medicinal …

    26 Feb 2002 · 62000CJ0023

  • Regulation (EU) 2021/96344Law

    … médicaments vétérinaires contenant du trembolone allyle ou des substances beta-agonistes aux fins indiquées à l’article 4 de la Directive 96/22/CE peuvent s’effectuer avant la fin de la période d’attente,conformément à …

  • Opinion of Mr Advocate General Ruiz-Jarabo Colomer delivered on 4 October 2001. Council of the European Union v Boehringer Ingelheim VetmediDecision

    The applicants at first instance sought the partial annulment, specifically of Articles 1 to 4, of Directive 96/22, the provisions of which should have been incorporated into the domestic law of the Member States by 1 July 1997, but the …

    4 Oct 2001 · 62000CC0023

  • Veterinärbehördliche Einfuhr- und Binnenmarktverordnung 199817Law

    … frisches Fleisch, das Rückstände von Stoffen enthält, die nach den Ausnahmeregelungen der Artikel 4, 5 und 7 der Richtlinie des Rates 96/22/EG oder der Verordnung BGBl. II Nr. 280/1997 zugelassen sind beziehungsweise das Rückstände …

  • Judgment of the Court (First Chamber) of 17 July 2008. cp-Pharma Handels GmbH v Bundesrepublik Deutschland.Decision

    Firstly, it is appropriate to note that the conditions under which Article 4 of Directive 96/22 allows Member States to authorise the administration of progesterone to farm animals include that of compliance with the requirements relating …

    17 Jul 2008 · 62006CJ0448

  • Opinion of Mr Advocate General Mazák delivered on 16 January 2008. cp-Pharma Handels GmbH v Bundesrepublik Deutschland.Decision

    In the Boehringer case, the Court examined whether the Commission when fixing the provisional MRL for a veterinary medicinal product, thereby listing it in Annex III to Regulation No 2377/90, can make reference to specific provisions of …

    16 Jan 2008 · 62006CC0448

  • College van Beroep voor het bedrijfsleven, 19-08-2009, AWB 07/550Decision

    … Er is bovendien geen sprake van de uitzonderingssituatie met betrekking tot landbouwhuisdieren zoals bepaald in artikel 4 van Richtlijn 96/22/EG van de Raad en artikel 81 van de Diergeneesmiddelenregeling. Appellante houdt immers slechts …

    19 Aug 2009 · ECLI:NL:CBB:2009:BJ6732